发明名称 DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE
摘要 Provided are compounds that are inhibitors of both rho kinase and of a monoamine transporter (MAT) act to improve the disease state or condition. Further provided are compositions comprising the compounds. Further provided are methods for treating diseases or conditions, the methods comprising administering compounds according to the invention. One such disease may be glaucoma for which, among other beneficial effects, a marked reduction in intraocular pressure (IOP) may be achieved.
申请公布号 US2015175549(A1) 申请公布日期 2015.06.25
申请号 US201514641962 申请日期 2015.03.09
申请人 Aerie Pharmaceuticals, Inc. 发明人 deLong Mitchell A.;Sturdivant Jill Marie;Royalty Susan M.
分类号 C07D217/04;C07D409/12;C07D417/12;C07D401/12 主分类号 C07D217/04
代理机构 代理人
主权项 1. A compound according to Formula II: and salts thereof, wherein R1, R2, and R3 are independently hydrogen, C1-C4 alkyl, aryl, C1-C4 alkyl aryl, C1-C4 alkyl heteroaryl, C1-C4 alkyl heterocyclyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 carbonyl, C1-C4 carbonylamino, C1-C4 alkoxy, C1-C4 sulfonyl, C1-C4 sulfonylamino, C1-C4 thioalkyl, C1-C4 carboxyl, or form a ring with each other or with A;wherein A is C1-C4 alkyl, or forms a ring structure with R1, R2, or R3;wherein B is hydrogen, an aryl group, a heteroaryl group, a cycloalkyl group, a heterocycloalkyl group, C1-C22 alkyl, C1-C22 alkyl aryl, C1-C22 alkyl heteroaryl, C2-C22 alkenyl, C2-C22 alkynyl, C1-C22 carbonyl, C1-C22 carbonylamino, C1-C22 alkoxy, C1-C22 sulfonyl, C1-C22 sulfonylamino, C1-C22 thioalkyl, or C1-C22 carboxyl;wherein X1, X2, and X3 are, independently, hydrogen, hydroxyl, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, amino, aminocarbonyl, nitro, cyano, C1-C4 carbonyl, C1-C4 carbonylamino, C1-C4 alkoxy, C1-C4 sulfonyl, C1-C4 sulfonylamino, C1-C4 thioalkyl, or C1-C4 carboxyl;wherein the double circle indicates an aromatic or heteroaromatic ring; andwherein each Z is independently a bond, C1-C4 alkyl, heteroalkyl, or an O atom.
地址 Research Triangle Park NC US